The Gaithersburg-based company will first appear at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, at 9:45 a.m. EDT. Following this, leadership moves to the Citi 2026 BioPharma Back to School Conference on Thursday, September 10, at 10:00 a.m. EDT. Both sessions will be accessible to the public via live webcasts hosted on the investor relations section of the Novavax website, with archived replays remaining available for 30 days post-event.
Novavax Executives Set for September Investor Circuit
Novavax management will headline two major healthcare investor gatherings in New York this month, signaling a push to update stakeholders on the company’s strategic trajectory. The biotechnology firm plans to address its current research and development initiatives during separate fireside chats scheduled for September 9 and September 10.
Novavax continues to center its corporate strategy on three pillars: technology partnerships, capital-efficient innovation, and a streamlined operating model. These appearances arrive as the company balances the commercialization of its Nuvaxovid and R21/Matrix-M vaccines with the broader application of its protein-based nanoparticle technology.
Comments (0)
No comments yet. Be the first!